Lexagene Holdings Inc (CVE:LXG)

Lexagene Holdings Inc (CVE:LXG)

Share Price
$ 0.70
0.02 (2.94 %)
Market Cap
$49.38 m
Proactive Investors - Run By Investors For Investors

Lexagene Holdings Inc

LexaGene is a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary diagnostics, food safety and for use in open-access markets such as clinical research, agricultural testing and biodefense. End-users simply need to collect a sample, load it onto the instrument with a sample preparation cartridge,...

Market: TSX-V:LXG
52-week High/Low: C$0.93 / C$0.50
Sector: Health Care, Equipment & Services
Market Cap: $49.38 m
Website: www.lexagene.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Lexagene Holdings Inc

Lexagene Holdings Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use